Previous 10 | Next 10 |
2024-07-15 07:45:00 ET When it comes to investing in growth stocks, a long-term mindset can be a lucrative advantage. Peering further into the future can enable you to position your portfolio for fortune-building gains. Here are two businesses with excellent long-term expansion prospects th...
2024-07-14 09:45:00 ET Great stocks can be found in any market environment, even if share prices fluctuate with time. However, solid businesses with great financials and durable growth pathways will typically reflect that with relatively steady share price increases over time. If you're loo...
2024-07-14 06:31:00 ET Shares of Eli Lilly (NYSE: LLY) have more than doubled over the past 12 months, but Wall Street analysts who watch the big pharma company think it has more fuel in the tank. For example, J.P. Morgan recently raised its price target on Eli Lilly to $1,0...
2024-07-14 05:20:00 ET Two pharma juggernauts, Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) , are picking up speed in their preparations for an epic battle to control the market for weight loss drugs. The prize for the victor will be a larger market share of what may b...
2024-07-13 15:34:06 ET More on Eli Lilly, ResMed, etc. What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Wall Street Lunch: Merger Monday In All Its Glory Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal Lilly expecting ...
2024-07-13 14:03:47 ET More on Amgen, Biogen, etc. Biogen's Diverse Drug Portfolio Faces Competitive Challenges In 2024 Merck: Positive Developments, But Watch The Q2 Earnings Biogen Stock: Cheapish, But With Few Growth Prospects This weight loss stock is the...
2024-07-13 09:00:00 ET Summary This article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of ...
2024-07-13 06:31:00 ET Eli Lilly (NYSE: LLY) received some great news from regulators last week: Its Alzheimer's treatment obtained the green light from the Food and Drug Administration (FDA). The new drug, Kisunla, has the potential to be a blockbuster for the company and gener...
2024-07-13 05:30:00 ET Pharmaceutical giant Eli Lilly (NYSE: LLY) has gotten off to an incredible start in 2024. The company's diabetes and obesity care treatments, Mounjaro and Zepbound, continue to support unprecedented growth for Lilly in a heated race with its rival Novo N...
2024-07-12 16:55:48 ET More on Eli Lilly What Eli Lilly Is Getting With The Acquisition Of Morphic Holding Wall Street Lunch: Merger Monday In All Its Glory Eli Lilly Targets IBD, Takes Calculated Gamble With $3.2bn Morphic Deal These are the weight loss drug...
News, Short Squeeze, Breakout and More Instantly...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...
2024-07-26 07:45:00 ET Over the last 18 months, the stock market has been incredibly generous to investors. Since January 2023, the S&P 500 has soared 45%, while the tech-heavy Nasdaq Composite has rocketed by 72%. Outside of the technology industry, investors have also foun...
2024-07-25 19:06:06 ET It wasn't so long ago when Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) stocks were flying high thanks to their hotly popular weight loss drugs (Wegovy/Ozempic for Novo Nordisk and Zepbound/Mounjaro for Lilly). In the pharmaceutical industry,...